Work

Incorporation of bevacizumab (B) and erlotinib (Er) with induction (Ind) and concurrent (Conc) carboplatin (Cb)/paclitaxel (P) and 74 Gy of thoracic radiotherapy in stage III non-small cell lung cancer (NSCLC)

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.7528

Authors: M. A. Socinski, T. E. Stinchcombe, J. S. Halle, D. T. Moore, W. J. Petty, A. W. Blackstock, S. N. Gettinger, R. H. Decker, A. H. Khandani, D. E. Morris

Institutions: University of North Carolina at Chapel Hill, Yale University, Wake Forest University

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1608184865

Cites:

Cited by: 8

Related to: 10